Skip to main content
SpringerLink
Log in

Prednison, Azathioprin und N-Acetylcystein bei Lungenfibrose

PANTHER-IPF-Studie

Prednisone, azathiorpine, and N-acetylcystene for pulmonary fibrosis

PANTHER-IPF study

  • Journal Club
  • Published:
Der Pneumologe Aims and scope

    We’re sorry, something doesn't seem to be working properly.

    Please try refreshing the page. If that doesn't work, please contact support so we can address the problem.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Demedts M, Behr J, Buhl R et al (2005) High-dose acetylcysteine in idiopathic pulmonary fibrosis. N Engl J Med 353:2229–2242

    Article  PubMed  CAS  Google Scholar 

  2. Hunninghake G (2005) Antioxidant therapy for idiopathic pulmonary fibrosis. N Engl J Med 353:2285–2287

    Article  PubMed  CAS  Google Scholar 

  3. The Idiopahic Pulmonary Fibrosis Clinical Research Network (2012) Prednisone, azathiorpine, and N-acetylcystene for pulmonary fibrosis. N Engl J Med DOI 10.1056/NEJMoa1113354

  4. Behr J, Costabel U, Worth H (2011) Comments of the DGP on the press release dated 21.10.2011 of the National Heart, Lung and Blood Institute about the PANTHER Study on IPF patients. Pneumologie 65(12):724–725

    Article  PubMed  CAS  Google Scholar 

  5. Wells AU, Behr J, Costabel U et al (2012) Triple therapy in idiopathic pulmonary fibrosis: an alarming press release. Eur Respir J 39:805–806

    Article  PubMed  CAS  Google Scholar 

  6. Azuma A, Nukiwa T, Tsuboi E et al (2005) Double-blind, placebocontrolled trial of pirfenidone in patients with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 171:1040–1047

    Article  PubMed  Google Scholar 

  7. Taniguchi H, Ebina M, Kondoh Y et al (2010) Pirfenidone in idiopathic pulmonary fibrosis. Eur Respir J 35:821–829

    Article  PubMed  CAS  Google Scholar 

  8. Noble PW, Albera C, Bradford WZ et al (2011) Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials. Lancet 377(9779):1760–1769

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Medizinischen Klinik III für Pneumologie, Allergologie, Schlaf- und Beatmungsmedizin, Berufsgenossenschaftliches Universitätsklinikum Bergmannsheil GmbH, Ruhr-Universität Bochum, Bürkle-de-la-Camp-Platz 1, 44789, Bochum, Deutschland

    J. Behr

Authors
  1. J. Behr
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to J. Behr.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Behr, J. Prednison, Azathioprin und N-Acetylcystein bei Lungenfibrose. Pneumologe 9, 459–460 (2012). https://doi.org/10.1007/s10405-012-0623-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10405-012-0623-x

Search

Navigation